536 related articles for article (PubMed ID: 27115411)
21. Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms.
Delattin N; Cammue BP; Thevissen K
Future Med Chem; 2014 Jan; 6(1):77-90. PubMed ID: 24358949
[TBL] [Abstract][Full Text] [Related]
22. Antifungal activity of a β-peptide in synthetic urine media: Toward materials-based approaches to reducing catheter-associated urinary tract fungal infections.
Raman N; Lee MR; Rodríguez López AL; Palecek SP; Lynn DM
Acta Biomater; 2016 Oct; 43():240-250. PubMed ID: 27422198
[TBL] [Abstract][Full Text] [Related]
23. Discovery of simplified sampangine derivatives as novel fungal biofilm inhibitors.
Liu N; Zhong H; Tu J; Jiang Z; Jiang Y; Jiang Y; Jiang Y; Li J; Zhang W; Wang Y; Sheng C
Eur J Med Chem; 2018 Jan; 143():1510-1523. PubMed ID: 29126739
[TBL] [Abstract][Full Text] [Related]
24. Genesis of Azole Antifungal Resistance from Agriculture to Clinical Settings.
Azevedo MM; Faria-Ramos I; Cruz LC; Pina-Vaz C; Rodrigues AG
J Agric Food Chem; 2015 Sep; 63(34):7463-8. PubMed ID: 26289797
[TBL] [Abstract][Full Text] [Related]
25. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
26. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
27. Medically important fungi respond to azole drugs: an update.
Zavrel M; White TC
Future Microbiol; 2015; 10(8):1355-73. PubMed ID: 26234644
[TBL] [Abstract][Full Text] [Related]
28. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.
Pfaller MA; Diekema DJ
J Clin Microbiol; 2004 Oct; 42(10):4419-31. PubMed ID: 15472288
[No Abstract] [Full Text] [Related]
29. Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013).
Castanheira M; Messer SA; Rhomberg PR; Pfaller MA
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):200-4. PubMed ID: 27061369
[TBL] [Abstract][Full Text] [Related]
30. Exopolysaccharides and Biofilms.
Le Mauff F
Curr Top Microbiol Immunol; 2020; 425():225-254. PubMed ID: 32072265
[TBL] [Abstract][Full Text] [Related]
31. Antifungal drug resistance of oral fungi.
Niimi M; Firth NA; Cannon RD
Odontology; 2010 Feb; 98(1):15-25. PubMed ID: 20155503
[TBL] [Abstract][Full Text] [Related]
32. Antifungals discovery: an insight into new strategies to combat antifungal resistance.
Fuentefria AM; Pippi B; Dalla Lana DF; Donato KK; de Andrade SF
Lett Appl Microbiol; 2018 Jan; 66(1):2-13. PubMed ID: 29112282
[TBL] [Abstract][Full Text] [Related]
33.
D'agostino M; Tesse N; Lavergne RA; Le Pape P; Frippiat JP; Machouart M; Debourgogne A
J Med Microbiol; 2021 Sep; 70(9):. PubMed ID: 34491156
[No Abstract] [Full Text] [Related]
34. Combination Therapy to Treat Fungal Biofilm-Based Infections.
Tits J; Cammue BPA; Thevissen K
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238622
[TBL] [Abstract][Full Text] [Related]
35. Our current understanding of fungal biofilms.
Ramage G; Mowat E; Jones B; Williams C; Lopez-Ribot J
Crit Rev Microbiol; 2009; 35(4):340-55. PubMed ID: 19863383
[TBL] [Abstract][Full Text] [Related]
36. Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces.
Katragkou A; Roilides E; Walsh TJ
Clin Infect Dis; 2015 Dec; 61 Suppl 6():S622-9. PubMed ID: 26567280
[TBL] [Abstract][Full Text] [Related]
37. Progress and prospects for targeting Hsp90 to treat fungal infections.
Veri A; Cowen LE
Parasitology; 2014 Aug; 141(9):1127-37. PubMed ID: 24560124
[TBL] [Abstract][Full Text] [Related]
38. Defining the frontiers between antifungal resistance, tolerance and the concept of persistence.
Delarze E; Sanglard D
Drug Resist Updat; 2015 Nov; 23():12-19. PubMed ID: 26690338
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of Antifungal Drug Resistance.
Cowen LE; Sanglard D; Howard SJ; Rogers PD; Perlin DS
Cold Spring Harb Perspect Med; 2014 Nov; 5(7):a019752. PubMed ID: 25384768
[TBL] [Abstract][Full Text] [Related]
40. Current status of antifungal resistance and its impact on clinical practice.
Alcazar-Fuoli L; Mellado E
Br J Haematol; 2014 Aug; 166(4):471-84. PubMed ID: 24749533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
